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Abstract
Background: MicroRNAs (miRNAs) are a class of short non-coding RNAs that regulate cell homeostasis by inhibiting
translation or degrading mRNA of target genes, and thereby can act as tumor suppressor genes or oncogenes. The role of
microRNAs in medulloblastoma has only recently been addressed. We hypothesized that microRNAs differentially expressed
during normal CNS development might be abnormally regulated in medulloblastoma and are functionally important for
medulloblastoma cell growth.
Methodology and Principal Findings: We examined the expression of microRNAs in medulloblastoma and then
investigated the functional role of one specific one, miR-128a, in regulating medulloblastoma cell growth. We found that
many microRNAs associated with normal neuronal differentiation are significantly down regulated in medulloblastoma. One
of these, miR-128a, inhibits growth of medulloblastoma cells by targeting the Bmi-1 oncogene. In addition, miR-128a alters
the intracellular redox state of the tumor cells and promotes cellular senescence.
Conclusions and Significance: Here we report the novel regulation of reactive oxygen species (ROS) by microRNA 128a via
the specific inhibition of the Bmi-1 oncogene. We demonstrate that miR-128a has growth suppressive activity in
medulloblastoma and that this activity is partially mediated by targeting Bmi-1. This data has implications for the
modulation of redox states in cancer stem cells, which are thought to be resistant to therapy due to their low ROS states.
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Introduction
Medulloblastoma is the most common malignant brain tumor of
childhood. While outcomes have improved, there is significant
therapy-related morbidity[1,2]. In addition, patients with high-risk
features continue to have a poor prognosis. Recent advances
indicate that medulloblastoma arises from cerebellar granule cell
precursors or neural stem cells located in the cerebellum[3,4,5,6].
While the molecular mechanisms involved in medulloblastoma
tumorigenesis are not well defined, it is clear that there is
abnormal control of normal developmental mechanisms[7].
Recently work from our lab and others have implicated
microRNAs as important regulators of medulloblastoma cell
growth[8,9,10]. MicroRNAs consist of 18–22 nucleotide RNA
molecules with post-transcriptional gene silencing activity [11].
Most commonly they control gene expression through association
with the 39-untranslated region (39 UTR) of genes and inhibit
protein translation[12]. MicroRNAs can also destabilize and
mediate the degradation of RNA transcripts[13]. In addition to
their role in normal development, microRNAs are also associated
with carcinogenesis[14,15]. Many microRNAs are under ex-
pressed in human tumors compared to normal tissues, while some
are over expressed [16]. Importantly, dysregulation of microRNA
processing results in enhanced tumorigenesis [17]. In addition, a
growing number of microRNAs are associated with specific
human cancers. For example, microRNA 21 (miR-21) is over
expressed in glioblastoma, and inhibition of miR-21 inhibits
glioblastoma growth in vitro and in vivo[18]. Others have shown
that miR-137 and miR-124 induces differentiation of glioma stem
cells[19]. We have previously shown that miR-124 also acts as a
tumor suppressor in medulloblastoma cells while other recent
studies have implicated the miR 17-92 polycistron as an oncogene
in sonic hedgehog mediated medulloblastoma [9,10,20].
These and other recent studies suggest that microRNAs are
critical regulators of tumorigenesis and that their contribution to
medulloblastoma tumorigenesis is important. Therefore, we
decided to investigate microRNA function in medulloblastoma.
We explored the possibility that expression of brain-enriched
PLoS ONE | www.plosone.org 1 June 2010 | Volume 5 | Issue 6 | e10748microRNAs is altered in medulloblastoma and that some of these
microRNAs may play a critical regulatory role in this tumor. We
found that several microRNAs associated with normal neuronal
differentiation are significantly down regulated in medulloblasto-
ma. Of these microRNA 128a (miR-128a) was strongly down
regulated. While the role of miR-128a has been investigated in
astrocytic tumors such as glioblastoma, its role in neuronal tumors
such as medulloblastoma is not known. Here we describe the
functional role of miR-128a in medulloblastoma for the first time.
We found that miR-128a inhibits growth of medulloblastoma cells
by targeting the Bmi-1 oncogene and thereby increasing the
steady-state levels of superoxide and promoting cellular senes-
cence.
Results
Brain enriched microRNAs are differentially expressed in
medulloblastoma
As a first step to addressing the role of microRNA in
medulloblastoma we performed microarray-based analysis of
microRNA in medulloblastoma cells and compared it to normal
adult human cerebellum. We chose to examine primary
medulloblastoma cell explants at passage 2 in culture to avoid
noise from contaminating elements of normal brain in biopsy
samples. Out of the 385 human microRNAs assayed, 167 were
expressed at lower levels in medulloblastoma when compared to
normal cerebellum. Hierarchical clustering of the microRNA
expression correctly separated the normal cerebellum from the
medulloblastoma samples (Figure S1-A). Further analysis revealed
that decreased expression of 90 microRNAs in medulloblastoma
were statistically significant (p,0.05). This list was then examined
to separate the microRNAs that were expressed in all three
cerebellar samples and statistically decreased in all three
medulloblastoma samples. This narrowed the list of statistically
significant human microRNAs with decreased expression in all
three medulloblastoma samples to 30 microRNAs (Figure S1-B).
Of note, many of the microRNAs had previously been identified as
being enriched in normal brain[21]. Some but not all of these
microRNAs were also reported previously as being decreased in
medulloblastoma as compared to normal cerebellum [8,9].
Comparison of the data sets of decreased microRNAs reported
previously and our data revealed that only five microRNAs were
detected by all three groups (Figure S2). These are miR-124, miR-
129, miR-138, miR-150 and miR-323. We have previously shown
that miR-124 is functionally important in medulloblastoma while
the biology of the other four common miRs is not yet clear[10].
Ferretti et al had an additional 12 microRNAs in common with our
data set where as Northcott et al had only 3 additional microRNAs
in common with us (Figure S2). Furthermore there were 10
additional microRNAs that were only identified by us as being
significantly decreased in medulloblastoma (Figure S2).
We next performed real time RT-PCR on a cohort of these
miRNA in additional samples to validate our microarray data
(Figure 1A). Comparing primary medulloblastoma cells to both
adult and pediatric normal cerebellum revealed a significant down
regulation of brain enriched microRNAs in medulloblastoma.
There are four highly down regulated microRNAs namely, miR-
125, miR-128a, miR -139 and let-7g. Of these four microRNAs,
miR-139 was identified by us but not in two previous reports[8,9].
Furthermore we as well as Ferretti et al but not Northcott et al
detected miR-128a as decreased in medulloblastoma. Interestingly
adult cerebellum had higher expression of many of these
microRNAs when compared to pediatric cerebellum. The
expression of highly repressed microRNAs was further validated
in a panel of medulloblastoma cell lines. Similar to the primary
explants all four microRNAs were decreased in the cell lines when
compared to normal cerebellum (Figure 1B). Consistent with
previously published data we also found miR17-5p to be over-
expressed in medulloblastoma[9].
Next we examined the expression of let-7g, miR-125 and miR-
128a in primary medulloblastoma tumors and normal cerebellar
tissue. Using qRT- PCR we found that all three miRNAs are
significantly decreased in expression in 10 archived medulloblas-
toma patient samples (ANOVA, p,0.001, Figure 1C). Given the
small sample set, it is difficult to develop any correlation with
tumor sub-type or patient outcomes. However the samples were
not Gli1 high and thus not in the SHH subcategory [9,22]. These
data indicate that these microRNAs could have an important
biological role in medulloblastoma. Based on the extent of miR-
128a repressed in medulloblastoma in contrast to its high
expression in normal cerebellum, we chose to further investigate
the functional role of miR-128a in medulloblastoma.
Re-expression of miR-128a decreases Daoy
medulloblastoma cell growth
To determine whether re-expression of microRNAs alters tumor
cell growth, we transfected Daoy medulloblastoma cells with
microRNA precursor oligonucleotides. These microRNA precursor
molecules are designed to mimic endogenous microRNAs. Re-
expression of miR-128a decreased medulloblastoma cell growth as
measured by the MTT assay (Figure 2A). Similar findings were
noted in the D283 medulloblastoma cell line (data not shown). To
further evaluate the growth inhibitory effect of miR-128a, we
transfected Daoy cells with control miR or miR-128a oligonucleo-
tides and counted cells for 5 days using the trypan blue dye exclusion
method. Consistent with the MTT data, miR-128a decreased Daoy
cell growth in a dose-dependent manner (Figure 2B).
To better evaluate the impact of microRNAs on medulloblas-
toma cells we used a lentiviral plasmid, which expresses the miR-
128a cassette and performed colony formation assays. As shown in
Figure 2C and D, transfection with miR-128a potently inhibited
colony formation by medulloblastoma cells indicating that miR-
128a is a putative tumor suppressor in medulloblastoma. In
addition miR-128a potently decreased the ability of Daoy cells to
grow in soft agar further suggesting a tumor suppressive role for
miR-128a in medulloblastoma (Figure S3).
MicroRNA 128a down regulates Bmi-1 in
medulloblastoma cells
We next performed an analysis of potential microRNA target
sites using two commonly used prediction algorithms, TargetS-
CAN (http://www.targetscan.org) and PicTar (http://pictar.bio.
nyu.edu) [23,24]. Both algorithms predicted the polycomb gene
Bmi-1 to be a target for miR-128a. The target site meets the seed
match criteria (Figure 3A). To experimentally test whether our
predicted targets were regulated by miR-128a, the Bmi-1 target
site was cloned in the 39UTR of the Renilla luciferase gene in the
siCHECK vector. Daoy cells were transfected with control or
miR-128a oligonucleotides. Co-transfection with miR-128a signif-
icantly decreased Renilla luciferase activity in the Bmi-1 target site
vectors but not in the mutated site vectors (Figure 3B). This data
suggests that Bmi-1 is a target of miR-128a. One other recent
study of miR-128a in glioma also reported that Bmi-1 is a target
for miR-128a[25]. This is especially exciting since polycomb genes
play a vital role in stem cell renewal during embryogenesis and are
also known to be biologically important in neural cell proliferation
and medulloblastoma pathogenesis[26–27].
miR-128a in Medulloblastoma
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performed immunoblot analysis of control or miR-128a transfect-
ed cells. Daoy cells were transfected with control or miR-128a
oligonucleotides and harvested 48 hours later. Western blot
analysis was performed using anti-Bmi-1 antibody. MiR-128a
decreased Bmi-1 protein levels in Daoy cells consistent with the
luciferase data. (Figure 3C, D).
MicroRNA 128a inhibits Bmi-1 mediated signaling
Bmi-1 is known to represses p16 expression[28]. In the absence of
Bmi-1, p16 is up regulated in neuronal stem cells reducing the cell
proliferation[26]. Also, it has been shown that Bmi-1 mediated
repression of p16 can lead to increased aggressive behavior of
melanoma stem cells[29]. Daoy and ONS76 medulloblastoma cells
transfected with miR-128a up-regulated p16 as detected by western
blotting (Figure 4A). The same cell lines when transfected with Bmi-1
completely repressed p16 expression. To further confirm that miR-
128a prevents the repression of p16 by inhibiting Bmi-1, both Daoy
and ONS76 cell lines were co-transfected with miR-128a and Bmi-1.
This resulted in a moderate increasein p16 protein level compared to
that of cells transfected only with Bmi-1.
Previous studies indicate that Bmi-1 inhibits p16 and thereby
enhances E2F1 activity[30]. The E2F transcription factors play a
key role in the regulation of cellular proliferation and terminal
differentiation. Therefore the effect of miR-128a on E2F1
transcriptional activity was examined. It was found that transfec-
tion of miR-128a into Daoy cells significantly decreased E2F1
activity as measured by luciferase reporter activity, p,0.05
(Figure 4B). This is consistent with our findings that miR-128a
decreases Bmi-1 and increases p16.
Bmi-1 is a functional component of miR-128a mediated
medulloblastoma cell growth arrest
To further evaluate whether Bmi-1 repression is a functional
component of the miR-128a growth arrest phenotype we
investigated whether Bmi-1 could rescue the miR-128a growth
arrest in medulloblastoma cells. Medulloblastoma cells were
transfected with miR-128a, miR-128a and Bmi-1 or the
corresponding controls and the cells subjected to the colony focus
assay. Co-transfection of miR-128a with Bmi-1 resulted in
attenuation of the miR-128a mediated growth arrest in both
Daoy cells (Figure 5A and B). Daoy cells co-transfected with Bmi-1
lacking its 39UTR and miR-128a also rescued the proliferation of
cells as inhibited by miR-128a alone (Figure S4A). This clearly
suggests that miR-128a targets Bmi-1 and decrease the cell
survival. Another medulloblastoma cell line ONS76 cells also
Figure 1. Down regulation of microRNAs in medulloblastoma. A) MicroRNA heat map profiling of medulloblastoma patient samples and
comparison to normal cerebellum. B) Repression of miR-125, miR-128, miR-139, let-7g and increased expression of miR17-5p in medulloblastoma cell
lines. C) Relative expression of microRNAs in medulloblastoma patient samples.
doi:10.1371/journal.pone.0010748.g001
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miR-128a and Bmi-1 (Figure S4B). This data functionally places
Bmi-1 in the miR-128a cascade.
MicroRNA 128a increases the steady-state level of
superoxide in Daoy cells
Recently it has been shown that the absence of Bmi-1 leads to
increased reactive oxygen species (ROS) levels in cells derived
from Bmi-1 knockout mice [31]. ROS are well known to modulate
a variety of cellular functions including cancer cell biology[32].
Given that miR-128a decreased Bmi-1 protein levels, we wanted
to test whether a similar rise in ROS levels was evident in Daoy
cells treated with miR-128a. We performed spin trapping of free
radicals and electron paramagnetic resonance (EPR) spectroscopy
to identify whether there was an increase of the ROS level in cells
re-expressing miR-128a. The spin trap, DMPO was chosen
because of its low cytotoxicity, accessibility to the cell, and reaction
with hydroxyl radicals (?OH) to yield a distinctive DMPO-OH
spin adduct [33]. The reaction of DMPO with superoxide yields a
product (DMPO-OOH) that is converted to DMPO-OH by GPx
in cells. Therefore, DMPO is a useful probe for detecting oxygen-
centered radicals arising from superoxide and H2O2. The EPR
spectra show a typical 1:2:2:1 DMPO-OH quartet (closed circles,
Figure 6A-ii). EPR results clearly show an increase in the DMPO-
OH quartet intensity in Daoy cells expressing miR-128a compared
to that of the empty vector (Figure 6A-i). To identify precisely
whether the DMPO-OH quartet signal could be due directly to
superoxide or to H2O2, Daoy cells transfected with miR-128a
were incubated with CuZnSOD for 30 min prior to the addition
of DMPO. Addition of SOD significantly decreased the EPR
signal height suggesting that the DMPO-OH signal is directly due
to superoxide (Figure 6A-iii). The quantitative analysis of the
quartet signal height (Figure 6B) demonstrated a significant
increase (p,0.05) of superoxide in cells transiently transfected
with miR-128a when compared to cells treated with the control
vector. This increase in signal intensity was inhibited by the
addition of SOD. It is therefore clear that miR-128a increases the
steady-state level of superoxide in medulloblastoma cells. To
further confirm that the increase in ROS is due to the inhibition of
Bmi-1, Daoy cells were co-transfected with Bmi-1 and miR-128a.
This resulted in a decreased ROS level in cells compared to that of
miR-128a alone (Figure 6A-iv). Rescue experiments with Bmi-1
Figure 2. Inhibition of medulloblastoma cell growth by microRNA-128a. A) MiR-128a inhibits medulloblastoma cell proliferation as
measured by MTT assay. (p,01) B) Number of Daoy cells as measured by trypan blue dye exclusion assay. C) Decreased colony formation in miR-128a
transfected cells (top row is miR-128a vector, bottom row is control vector). D) Colony counts in triplicate of 2 independent experiments. (p,0.001)
doi:10.1371/journal.pone.0010748.g002
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reporter assays indicate that miR-128a functionally targets the wt Bmi-1 39UTR, *p,0.01 C) Western blot analysis confirms that miR-128a, but not the
control miR (CM), inhibits protein expression of Bmi-1 in medulloblastoma cells. D) Quantitation of Western blot bands. (p,0.01)
doi:10.1371/journal.pone.0010748.g003
Figure 4. Growth inhibition signaling pathways modulated by miR-128a. A) Western blot analysis showed increased p16 expression in Daoy
cells transfected with miR-128a compared to that of the control vector, pVETL. The level of p16 expression was completely inhibited in Daoy cells that
were transfected with the Bmi-1 vector alone while modest inhibition was observed in cells co-transfected with miR-128a. B) Decreased E2F1 activity
in Daoy cells transfected with miR-128a as measured by luciferase reporter assays. (p,0.01)
doi:10.1371/journal.pone.0010748.g004
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thus leads to increase in ROS level in cells (Figure S5)
MicroRNA 128a induces cell senescence in Daoy cells
Reactive oxygen species, a byproduct of oxidative stress can
induce irreversible cell growth arrest and senescence[34].
Furthermore senescing cells have significantly more ROS when
compared to apoptotic cells[35]. In addition p16 expression is one
of the hall marks of cellular senescence[36]. Given that we found
miR-128a transfected Daoy cells showed increased in the steady
state level of ROS, increased in p16 protein level and
demonstrated a cell growth arrest, we performed an assay for
senescence. Five days after transfection with miR-128a, an
increased number of senescence-associated b-galactosidase (SA-
b-Gal) positive cells were observed (Figure 7A). There was a five-
fold increase in senescent cells after miR-128a transfection of cells
when compared to the empty vector transfected cells (Figure 7B)
Similar data was observed in ONS 76 medulloblastoma cells
(Figure S6).
To further support our finding that miR-128a transfection leads
to cellular senescence, we examined the methylation levels of
histone 3, lysine 9 (H3K9) by western blotting. Senescence-
associated heterochromatin foci are associated with methylation of
histone 3 lysine 9 (H3K9me2). Interestingly, re-expression of miR-
128a resulted in increased methylation of histone 3 lysine 9
(H3K9me2), another mark of repressed gene expression mediated
by the Bmi-1 polycomb repressor complex (Figure 7C). All these
results strongly suggest that the growth inhibitory effect of miR-
128a is due to the senescence-signaling pathway as triggered by the
increase in ROS
Discussion
Here we report the novel regulation of reactive oxygen species
by microRNA 128a via the specific inhibition of the Bmi-1
oncogene. The functional role of microRNA 128a in medullo-
blastoma has not previously been described.
We found significant down regulation of several microRNAs
known to be involved in CNS development in medulloblastoma,.
Our data is in line with previous studies that have described
decreased expression of microRNAs in medulloblastoma[8,9].
Ferretti et al found 55 microRNAs to be down regulated in
medulloblastoma with differences in expression among the major
histological subtypes[8]. Similarly Northcott et al found 61
microRNAs to be decreased in medulloblastoma when compared
to normal cerebellum[9]. Interestingly when further classified into
4 molecular groups there were significant differences in micro-
RNA expression. For example the Sonic Hedge Hog (SHH) driven
tumors had decreased expression of 10 microRNAs but none that
overlapped with microRNAs identified by us or by Ferretti et al.
Indeed comparison analysis revealed significant differences
between the microRNAs detected by the three groups (Figure
S2). These differences are likely related to the platforms used by
each group, tumor source and the source and age of the normal
cerebellum used. We used primary cell explants in culture at
passage 2 while the other two groups used biopsy material.
Figure 5. Bmi-1 rescues miR-128a mediated growth arrest of medulloblastoma cells. A) Co-transfection of Daoy cells with miR-128a and
Bmi-1 increased the number of colonies formed compared to that of miR-128a alone. B) Quantitative analysis of the number of colonies formed by
Daoy cells after different transfections, including Bmi-1 that lacks its 39UTR. pBABE-puro is a control vector for the full length Bmi-1. *p,0.05 for miR-
128a vs. pVETL and **p,0.001 for miR-128a vs. miR-128a + Bmi-1.
doi:10.1371/journal.pone.0010748.g005
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and did not have a gene expression signature for SHH. Of note
both our study and the report by Ferretti et al. found that miR-
128a was significantly decreased in expression in medulloblastoma
when compared to normal cerebellum.
We show that this decreased expression is a property of primary
tumor samples as well as a panel of commonly used medulloblas-
toma cell lines. This data will be of particular use as microRNA
function is further probed in medulloblastoma. Of note the
miR17-5p cluster was over expressed in our samples, which is
consistent with previous reports[9].
The analysis of re-expressing miR-128a in medulloblastoma
cells showed that miR-128a inhibited the growth of medulloblas-
toma cells most likely by decreasing proliferation. MiR-128a
demonstrated tumor suppressive effects by potently inhibiting the
colony formation of medulloblastoma cells. Further analysis of
possible mechanisms revealed that the Bmi-1 oncogene was a
putative target of miR-128a. We demonstrated that Bmi-1 protein
is down regulated by miR-128a, which in turn leads to an increase
in p16 a cell cycle inhibitor. Regulation of Bmi-1 by microRNAs is
exciting given that Bmi-1 is over-expressed in medulloblastoma
and critical for normal cerebellar development[27]. Bmi-1 is also
critical for neural stem cell self-renewal [26]. Bmi-1 was also
recently shown to be a target of miR-128a in glioblastoma[25].
Our data extends this observation by demonstrating that
inhibition of Bmi-1 is functionally critical for the miR-128a
growth suppressive function. Restoring Bmi-1 expression in miR-
128a expressing cells rescues the medulloblastoma cells from
growth arrest. We then sought to further explore the mechanism of
the miR-128a-Bmi-1 pathway in medulloblastoma.
Recent data suggests that Bmi-1 regulates reactive oxygen
species[31]. We show that microRNA 128a induces intracellular
superoxide generation, possibly by regulating Bmi-1 levels and that
Bmi-1 re-expression reverses the superoxide generation. Recent
evidence suggests that cancer stem cells are more resistant to
therapy due to a lower overall redox state[37]. Thus modulating
regulatory mechanisms of ROS generation in cancer stem cells
maybe a useful strategy to destroy these cells. We envision a
scenario in which microRNA 128a can be used to induce ROS in
medulloblastoma stem cells and thereby make them more
radiosensitive. The key is to modulate the homeostasis of ROS.
At normal concentrations, ROS play a role in cellular functions
involving signal transduction. However, an imbalance between
generation of ROS and capacity of antioxidants to neutralize ROS
can result in a disruption of cellular redox status, leading to
oxidative stress. Our observation of an increased steady-state level
of ROS, and induction in p16 may contribute to premature-
senescence in cells expressing miR-128a (Figure S7).
In summary, we describe the functional role of microRNA 128a
in medulloblastoma. We demonstrate that microRNA 128a
decreases medulloblastoma cell growth through mechanisms
involving ROS and senescence. We are now investigating the
Figure 6. MiR-128a increases intracellular ROS by targeting Bmi-1. A) Increased superoxide radical formation in Daoy cells that were
transfected with miR-128a as detected using EPR spectra of the DMPO-OH spin adduct (closed circles in (ii)). The spectra collected are a signal
average of 15 scans. The 1:2:2:1(closed circles) quartet signal seen is due to the formation of DMPO-OH. The cells treated with miR-128a have ,3 fold
increase in ROS signal intensity (ii) as compared to the empty vector (i). Co-transfection of cells with miR-128a and Bmi-1 resulted in a decreased ROS
level compared to that of miR-128a alone (iii). The treatment of SOD in miR-128a-transfected cells abolished the signals showing that the radical
formed is mainly superoxide (iv). B) The quantitative analysis of EPR peak height normalized to cell number. *p,0.05 miR128a vs. pVETL and miR-
128a + SOD.
doi:10.1371/journal.pone.0010748.g006
miR-128a in Medulloblastoma
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using in vivo orthotopic xenograft models.
Materials and Methods
Cells, Tissues, and Culture
Daoy and D283 medulloblastoma cells were obtained from
American Type Culture Collection (Rockville, Md.) and cultured
in DMEM medium (Gibco, Grand Island, N.Y.) supplemented
with 10% fetal bovine serum (Gibco) according to the supplier’s
recommendations. Cell line ONS76 was kindly provided by Dr.
James T. Rutka (University of Toronto, Canada) and was cultured
in DMEM containing 10% FBS. D341 was obtained from ATCC
and cultured in DMEM with 20% FBS and 1% of sodium
pyruvate and L-glutamine. Primary cell cultures were derived
from biopsy specimens of medulloblastoma patients under a
protocol approved by the Institutional Review Board at the
University of Iowa Hospitals and Clinics. Written consent from all
patients was obtained as mandated by the University of Iowa IRB.
Cultures were maintained at low passage numbers (p2–p4) in
DMEM medium supplemented with 20% fetal bovine serum.
Normal human cerebellum and medulloblastoma patient samples
were obtained from the Pediatric Co-operative Human Tissue
Network (Columbus, Ohio) under a University of Iowa IRB
approved protocol. All samples were obtained in an anonymous
fashion as mandated by the IRB. Samples we Normal cerebellar
samples were from nonmalignant pediatric and adult brain. All
medulloblastoma samples were from pediatric patients. Details of
patient samples have been previously described [38]. Briefly all
samples were from non-metastatic (M0) tumors with classical
medulloblastoma histology.
MicroRNA Isolation and Quantitative PCR analysis
Small RNAs were isolated using the mirVANA RNA isolation
kit (Ambion).
MicroRNA expression was measured by quantitative PCR
using an ABI 7700 thermal-cycler. MicroRNA primers and probes
were purchased from Applied Biosystems (Foster City, CA) and
the assays performed per the manufacturer’s recommendations
with several modifications to enable us to detect low abundance
microRNAs. For the reverse transcription (RT) reaction 20
nanograms of total RNA was used. For the qPCR reaction the
resultant cDNA was diluted 1:2. Each RT step was performed in
duplicate and the qPCR in triplicate for each RT reaction. U6b
and U66 small RNAs were used as endogenous controls and
relative microRNA quantity calculated by the DDCT method.
Transient transfection of Daoy cells with miR-128a and
analysis of cell Proliferation and Viability
Cell proliferation was measured by MTT assay and cell viability
was determined by trypan blue dye exclusion assay. To assay for
Figure 7. MiR-128a promotes senescence in medulloblastoma cells. A) MiR-128a induces senescence in medulloblastoma cells as detected
by SA-beta galactosidase staining (dark blue cells; examples indicated by red arrows). B) Cell counts per High Powered Field of b-gal positive cells in
control vector (pVETL) or miR-128a transfected cells, *p=0.003. C) Western blot analysis showing increased level of H3K9me2 protein in Daoy cells
transfected with miR-128a when compared to the empty vector. Actin is used as an internal control.
doi:10.1371/journal.pone.0010748.g007
miR-128a in Medulloblastoma
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control miR, miR-9 or miR-128a oligonucleotide in 24 well plates
using LT1 reagent (Mirus, Madison WI). 6, 000 cells/well were
then seeded in triplicate in to 96 well plates in 100 ul of medium.
After 2 days, 100 ul of Cell Titer AQeous (Promega, Madison, WI)
was added and cells incubated for 1 hour and the absorbance
measured at 490 nm using a microplate reader per the
manufacturers recommendations. Relative cell number was
calculated by normalizing the absorbance to untreated cells.
To assay for cell viability, Daoy cells were seeded in a 6 well
plate and 24 h later cells were transfected with control miR or
with two different concentrations of miR-128a oligonucleotide.
The cell viability was measured every day for upto 5 days after the
transfection. Day 0 is the day of transfection.
Clonogenic assay. The ability of Daoy cells to clonally
expand and create colonies with and without either miR-128a or
Bmi-1 transfection or co- transfection with both miR-128a and
Bmi-1 was measured. Daoy cells were seeded for colony formation
48 h after transfection. After 7 days of incubation at 37uC,
colonies were stained with 0.5% crystal violet. Individual colonies
(.50 cells) were counted using an Olympus SZ51 (Leeds
Instruments) inverted microscope.
Luciferase assay and Western Blotting
Luciferase experiments were done using the siCHECK dual
luciferase system (Promega, Madison, WI). The putative miR-
128a target sites from the BMI-1 39 UTR were cloned into the
39UTR of the Renilla luciferase gene. Cells were transfected with
0.5 ug of the siCHECK plasmid using LT1(Mirus, Madison, WI)
and Renilla luciferase activity was measured 48 hours after
transfection and normalized to firefly luciferase. Some cells were
co-transfected with 50 or 100 nM miR-128a microRNA oligonu-
cleotide (Ambion, Texas). Western blotting was performed per
standard methods. The primary antibodies used were rabbit
polyclonal anti-Bmi-1 (Cell Signaling Technology, Danvers, MA);
mouse monoclonal anti-P16 (Santa Cruz Biotechnology Inc.,
Santa Cruz, CA.) and rabbit polyclonal anti-H3K9 (Cell Signaling
Technology, Danvers, MA.). The primary antibody dilutions were
1:1000. Horseradish peroxidase secondary antibodies were
detected by chemiluminescence (SupersignalH West Dura extend-
ed duration substrate from Thermo Scientific)
E2F activity was measured using luciferase reporters (Cignal
Finder Reporter, SA Biosciences) per the manufacturers instruc-
tions. Cells were seeded in 6 well plates containing luciferase
reporters to E2F with surefect transfection reagent. Luciferase
activity was measured using the Dual Luciferase Assay system
(Promega) on a Glomax multi luminometer (Promega). Firefly
luciferase was experimental E2F reporter and Renilla luciferase
was the normalizing reporter.
EPR spin trapping analysis of ROS
The formation of superoxide in Daoy cells transfected with
either miR-128a, Bmi-1, control vector or with both miR-128a
and Bmi-1 was followed by electron paramagnetic resonance
(EPR). EPR spin trapping technique with DMPO was used to
detect the level of superoxide (O2
N-). This technique involves an
addition reaction of a short-lived radical to a diamagnetic
compound (spin trap, here DMPO) to form a more stable free
radical product (spin adduct), which can be studied by EPR. The
intensity of the spin adduct signal corresponds to the amount of
short-lived radicals trapped; the hyperfine couplings of the spin
adduct are characteristic of the original trapped radical. In brief,
after 48 h of transfection, cell monolayers were washed with PBS
and incubated with 100 mM DMPO in chelated- PBS (pH 7.4) for
20 min. The specificity of the superoxide signal was determined by
pre-treating the cells with CuZnSOD (1000 U/ml) for 30 minutes.
The cells were then transferred to a TM quartz flat cell and EPR
spectra were recorded using a Bruker EMX spectrometer
equipped with a TM cavity. EPR spectra were obtained as an
average of 15 scans with a modulation amplitude of 1 G; scan rate
80 G/81 s; receiver gain 10
4–10
6; microwave power, 40 mW; and
modulation frequency of 100 kHz. The EPR peak heights are in
arbitrary units.
Cellular senescence analysis
At day 5 after transfection with miR-128a or control miRNA,
Daoy cells were fixed and stained by using an SA-beta-gal kit (Cell
Signaling Technology) according to the manufacturer’s instruc-
tions. The blue senescent cells were distinguished from viable cells
under the microscope. Four high power fields per sample were
counted in three independent samples to quantify the number of
senescent cells.
Statistical Analysis
P values were calculated using a student’s t-test. Error bars are
depicted as mean 6 standard error.
Supporting Information
Figure S1 Differential expression of microRNA in medulloblas-
toma. A) Heat map of miRNA found to be significantly different
between Cerebellum and Medulloblastoma. The top of the figure
indicates relationships between various samples and the left hand
side shows relationships of various microRNAs. Blue indicates low
expression and red indicates high expression. B) Thirty-one
microRNAs had statically significant decrease in expression in
all three medulloblastoma samples. Mean expression in cerebel-
lum and medulloblastoma is shown along with p values.
Found at: doi:10.1371/journal.pone.0010748.s001 (1.56 MB TIF)
Figure S2 Venn diagram of microRNAs decreased in medullo-
blastoma as detected by us (R), Northcott et al. (N) and Ferretti et
al. (F). Only 5 microRNAs were commonly detected by all three
groups.
Found at: doi:10.1371/journal.pone.0010748.s002 (1.56 MB TIF)
Figure S3 Anchorage independent growth of Daoy cells
overexpressing miR-128a. A) Growth of Daoy cells on soft agar
is decreased by miR-128a. B) Colony counts from soft agar assay.
Found at: doi:10.1371/journal.pone.0010748.s003 (1.56 MB TIF)
Figure S4 A) Clonogenic assay of Daoy cell lines showing the
rescuing effect of Bmi-1. Cells were transfected with different
plasmids to confirm the role of miR-128a in targeting Bmi-1. Co-
transfection with miR-128a and Bmi-1 that lacks its 3’UTR
rescued the cells from the inhibitory effect of miR-128a alone on
the cell colony forming ability. Cells transfected with only Bmi-1
plasmid that lacks its 3’UTR increased the cell plating efficiency
significantly (p,0.05). B) Colony forming ability of ONS76
transfected with empty vector, miR-128a, full length Bmi-1, co-
transfection with miR-128a and Bmi-1 or Bmi-1 alone.
Found at: doi:10.1371/journal.pone.0010748.s004 (1.56 MB TIF)
Figure S5 EPR experiments: Daoy cells transfected with
different plasmids to determine the alterations to the level of
ROS. Cells transfected with either full length Bmi-1 or Bmi-1
lacking its 3’UTR showed decrease in the level of ROS compared
to that of cells transfected with miR-128a. Co-transfection of cells
with both miR-128a and Bmi-1 lacking its 3’UTR resulted in
decrease in ROS compared to that of cells transfected with miR-
miR-128a in Medulloblastoma
PLoS ONE | www.plosone.org 9 June 2010 | Volume 5 | Issue 6 | e10748128a alone. Empty vectors I, II, III are controls for Bmi-1 lacking
its 3’UTR, pBABE-puro for full length Bmi-1 and for shRNA for
Bmi-1 respectively.
Found at: doi:10.1371/journal.pone.0010748.s005 (1.56 MB TIF)
Figure S6 Senescence in ONS76: Overexpression of miR-128a
in the medulloblastoma cell line ONS76 showed an increase in
senescence when compared to the control vector. This increase in
senescence was inhibited by Bmi-1 transfection.
Found at: doi:10.1371/journal.pone.0010748.s006 (1.56 MB TIF)
Figure S7 Schematic representation of the suggested senescence
pathway regulated by miR-128a via targeting Bmi-1 in medullo-
blastoma cells based on our results.
Found at: doi:10.1371/journal.pone.0010748.s007 (1.56 MB TIF)
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